Plasmacytoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Clinical Trials
• Forums

Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma
Condition:   PlasmacytomaInterventions:   Drug: Lenalidomide;   Drug: Dexamethasone;   Other: No further treatmentSponsors:   University College, London;   Cancer Research UK;   Celgene CorporationNot yet recruiting - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2015 Category: Research Source Type: clinical trials